UPCOMING EVENTS

Cares Diabetes Calendar of Events

Nov
17
Tue
Diabetes CARES Grand Rounds Smart Reach Simulcast Replay
Nov 17 2020 @ 12:00 am – Nov 17 2021 @ 11:59 pm

Diabetes CARES Grand Rounds Smart Reach Simulcast Replay

The CARES Approach: Improving Glycemic, Cardiovascular, and Renal Outcomes

View Activity

PROGRAM CHAIR

Silvio Inzucchi, MD
Professor of Medicine, Endocrinology
Yale School of Medicine
New Haven, CT 

SPEAKER FACULTY

Anne Peters, MD
Director, USC Clinical Diabetes Program
Professor of Clinical Medicine
Keck School of Medicine of USC
Los Angeles, CA

PROGRAM OVERVIEW

This activity will cover the treatment and management of patients with type 2 diabetes mellitus (T2DM).

TARGET AUDIENCE

This educational activity is intended for cardiologists, endocrinologists, primary care physicians, NPs, PAs, nurses, and other clinicians involved in the treatment of patients with T2DM.

LEARNING OBJECTIVES

On completing the program, attendees should be able to:

  • Personalize the selection of therapies for the management of cardiovascular and renal risk in patients with T2DM based on up-to-date standards of care
  • Determine the clinical implications of results from cardiovascular outcomes trials of SGLT2 inhibitors and GLP-1 receptor agonists
  • Utilize guidelines-based strategies for treatment intensification in patients with T2DM not meeting their glycemic goals

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved and/or interested in the therapeutic management of patients with T2DM.

CNE Credits:
1.0 ANCC Contact Hour

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

AMERICAN OSTEOPATHIC ASSOCIATION CREDIT INFORMATION

The AOA Bureau of OMED is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The AOA Bureau of OMED, as a co-sponsor with Med Learning Group, designates this enduring program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participant in this activity.

COMMISSION ON DIETETIC REGISTRATION CREDIT INFORMATION

This program has received prior approval with the Commission on Dietetic Registration for Dietitians and RDs. Credits: 1.0 Contact Hour(s)

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Faculty Member Disclosure
Silvio Inzucchi, MD Dr. Inzucchi reports that he serves as a consultant for Boehringer Ingelheim, AstraZeneca, Sanofi/Lexicon, Novo Nordisk, Merck, vTv Therapeutics, Zafgen, Abbott/Alere, Eisai (TIMI). He has also received royalties from McGraw-Hill and Uptodate and has received salary from Elsevier.
Anne Peters, MD Dr. Peters reports that she is on the speakers bureau for Novo Nordisk. She also serves as a consultant for Abbott Diabetes Care, Boehringer Ingelheim, Eli Lilly and Company, Livongo, MannKind, Merck, Novo Nordisk, Sanofi, and Pendulum Therapeutics. Dr. Peters has received research support from Dexcom, vTv Therapeutics, and donated devices from Abbott Diabetes Care. She also has stock options from Mellitus Health, Omada Health, Stability Health, Pendulum Therapeutics, and Livongo.

 

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review

The content of this activity was independently peer reviewed.

The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Lauren Bartunek, Program Manager for Med Learning Group, has nothing to disclose.
Marcello A. Morgan, MD, MPH, Medical and Scientific Services for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures
  2. Participate in the enduring activity
  3. Complete posttest and evaluation form online.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based.

This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

View Activity

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only.  Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Oct
25
Mon
Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes
Oct 25 @ 12:00 pm – 1:00 pm

Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes

REGISTER FOR WORKSHOP

Monday, October 25, 2021

12:00PM – 1:00PM ET

Please note this virtual program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.

Presenting Faculty:

Michael J. Blaha, MD, MPH (CARDIOLOGIST)
Professor of Medicine and Epidemiology
Director of Clinical Research,
Ciccarone Center for the Prevention of Cardiovascular Disease
Johns Hopkins University School of Medicine
Baltimore, MD

Jay Shubrook, DO, FACOFP, FAAFP (PRIMARY CARE)
Professor and Diabetologist
Director for Clinical Research
Director of Diabetes Service
Touro University
Vallejo, CA

Learning Objectives

After completing the CME activity, learners should be better able to:

  • Determine the clinical implications of results from Cardiovascular Outcomes Trials of GLP-1 receptor agonists
  • Identify patients with type 2 diabetes (T2DM) who are most likely to benefit from the use of GLP-1 receptor agonists
  • Personalize the selection of GLP-1 receptor agonists based on indications, guidelines recommendations and clinical data
  • Develop strategies for increasing collaboration between cardiologists and PCPs in managing cardiovascular risk in patients with T2DM

Target Audience

This educational activity is intended for cardiologists and primary care providers who manage and treat patients with type 2 diabetes.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved in the care of pa­tients with type 2 diabetes mellitus.

Credits:
1.0 ANCC Contact Hour

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

REGISTER FOR WORKSHOP

Oct
27
Wed
Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes
Oct 27 @ 12:00 pm – 1:00 pm

Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes

REGISTER FOR WORKSHOP

Wednesday, October 27, 2021

12:00PM – 1:00PM ET

Please note this virtual program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.

Presenting Faculty:

Michael J. Blaha, MD, MPH (CARDIOLOGIST)
Professor of Medicine and Epidemiology
Director of Clinical Research,
Ciccarone Center for the Prevention of Cardiovascular Disease
Johns Hopkins University School of Medicine
Baltimore, MD

Jay Shubrook, DO, FACOFP, FAAFP (PRIMARY CARE)
Professor and Diabetologist
Director for Clinical Research
Director of Diabetes Service
Touro University
Vallejo, CA

Learning Objectives

After completing the CME activity, learners should be better able to:

  • Determine the clinical implications of results from Cardiovascular Outcomes Trials of GLP-1 receptor agonists
  • Identify patients with type 2 diabetes (T2DM) who are most likely to benefit from the use of GLP-1 receptor agonists
  • Personalize the selection of GLP-1 receptor agonists based on indications, guidelines recommendations and clinical data
  • Develop strategies for increasing collaboration between cardiologists and PCPs in managing cardiovascular risk in patients with T2DM

Target Audience

This educational activity is intended for cardiologists and primary care providers who manage and treat patients with type 2 diabetes.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved in the care of pa­tients with type 2 diabetes mellitus.

Credits:
1.0 ANCC Contact Hour

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

REGISTER FOR WORKSHOP

Grand Rounds @ Macon, GA
Oct 27 @ 12:30 pm – 1:30 pm

Wednesday, October 27, 2021
12:30-1:30pm

Location
Macon, GA

Speaker
Silvio Inzucchi, MD

Nov
2
Tue
Grand Rounds @ Brooklyn, NY
Nov 2 @ 12:30 pm – 1:30 pm

Tuesday, November 2, 2021
12:30-1:30pm

Location
Brooklyn, NY

Speaker
Silvio Inzucchi, MD

Nov
3
Wed
Summit Meeting
Nov 3 @ 7:00 pm – 8:30 pm

Date
Wednesday, November 3, 2021
7:00-8:30 PM

Nov
10
Wed
Grand Rounds @ Richmond, IN
Nov 10 @ 7:30 am – 8:30 am

Wednesday, November 10, 2021
7:30-8:30am

Location
Richmond, IN

Speaker
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP

Nov
12
Fri
Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes
Nov 12 @ 3:00 pm – 4:00 pm

Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes

REGISTER FOR WORKSHOP

Friday, November 12, 2021

3:00PM – 4:00PM ET

Please note this virtual program is 3:00PM Eastern, 2:00PM Central, 1:00PM Mountain and 12:00PM Pacific.

Presenting Faculty:

Michael J. Blaha, MD, MPH (CARDIOLOGIST)
Professor of Medicine and Epidemiology
Director of Clinical Research,
Ciccarone Center for the Prevention of Cardiovascular Disease
Johns Hopkins University School of Medicine
Baltimore, MD

Jay Shubrook, DO, FACOFP, FAAFP (PRIMARY CARE)
Professor and Diabetologist
Director for Clinical Research
Director of Diabetes Service
Touro University
Vallejo, CA

Learning Objectives

After completing the CME activity, learners should be better able to:

  • Determine the clinical implications of results from Cardiovascular Outcomes Trials of GLP-1 receptor agonists
  • Identify patients with type 2 diabetes (T2DM) who are most likely to benefit from the use of GLP-1 receptor agonists
  • Personalize the selection of GLP-1 receptor agonists based on indications, guidelines recommendations and clinical data
  • Develop strategies for increasing collaboration between cardiologists and PCPs in managing cardiovascular risk in patients with T2DM

Target Audience

This educational activity is intended for cardiologists and primary care providers who manage and treat patients with type 2 diabetes.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved in the care of pa­tients with type 2 diabetes mellitus.

Credits:
1.0 ANCC Contact Hour

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

REGISTER FOR WORKSHOP

Nov
17
Wed
Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes
Nov 17 @ 12:00 pm – 1:00 pm

Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes

REGISTER FOR WORKSHOP

Wednesday, November 17, 2021

12:00PM – 1:00PM ET

Please note this virtual program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.

Presenting Faculty:

Michael J. Blaha, MD, MPH (CARDIOLOGIST)
Professor of Medicine and Epidemiology
Director of Clinical Research,
Ciccarone Center for the Prevention of Cardiovascular Disease
Johns Hopkins University School of Medicine
Baltimore, MD

Jay Shubrook, DO, FACOFP, FAAFP (PRIMARY CARE)
Professor and Diabetologist
Director for Clinical Research
Director of Diabetes Service
Touro University
Vallejo, CA

Learning Objectives

After completing the CME activity, learners should be better able to:

  • Determine the clinical implications of results from Cardiovascular Outcomes Trials of GLP-1 receptor agonists
  • Identify patients with type 2 diabetes (T2DM) who are most likely to benefit from the use of GLP-1 receptor agonists
  • Personalize the selection of GLP-1 receptor agonists based on indications, guidelines recommendations and clinical data
  • Develop strategies for increasing collaboration between cardiologists and PCPs in managing cardiovascular risk in patients with T2DM

Target Audience

This educational activity is intended for cardiologists and primary care providers who manage and treat patients with type 2 diabetes.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved in the care of pa­tients with type 2 diabetes mellitus.

Credits:
1.0 ANCC Contact Hour

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

REGISTER FOR WORKSHOP

Nov
22
Mon
Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes
Nov 22 @ 12:00 pm – 1:00 pm

Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes

REGISTER FOR WORKSHOP

Monday, November 22, 2021

12:00PM – 1:00PM ET

Please note this virtual program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.

Presenting Faculty:

Michael J. Blaha, MD, MPH (CARDIOLOGIST)
Professor of Medicine and Epidemiology
Director of Clinical Research,
Ciccarone Center for the Prevention of Cardiovascular Disease
Johns Hopkins University School of Medicine
Baltimore, MD

Jay Shubrook, DO, FACOFP, FAAFP (PRIMARY CARE)
Professor and Diabetologist
Director for Clinical Research
Director of Diabetes Service
Touro University
Vallejo, CA

Learning Objectives

After completing the CME activity, learners should be better able to:

  • Determine the clinical implications of results from Cardiovascular Outcomes Trials of GLP-1 receptor agonists
  • Identify patients with type 2 diabetes (T2DM) who are most likely to benefit from the use of GLP-1 receptor agonists
  • Personalize the selection of GLP-1 receptor agonists based on indications, guidelines recommendations and clinical data
  • Develop strategies for increasing collaboration between cardiologists and PCPs in managing cardiovascular risk in patients with T2DM

Target Audience

This educational activity is intended for cardiologists and primary care providers who manage and treat patients with type 2 diabetes.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.

NURSING CREDIT INFORMATION

Purpose:
This program would be beneficial for nurses involved in the care of pa­tients with type 2 diabetes mellitus.

Credits:
1.0 ANCC Contact Hour

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

REGISTER FOR WORKSHOP

Font Size